However, several studies have observed that human tumor cells release soluble MICA by proteolytic shedding and that these sMICA molecules result in the downregulation of NKG2D and impede NKG2D-mediated tumor immune surveillance (89–91). The gene discussed is KLRK1; the disease is neoplasm.